Trial Profile

A Randomized, Double-Blind, Clinical Trial Evaluating Three Single Dose Regimens With Loperamide for Treatment of Ambulatory Watery Travelers' Diarrhea, and Azithromycin With and Without Loperamide for Treatment of Ambulatory Dysentery/Febrile Diarrhea

Status: Discontinued

Phase of Trial: Phase IV

Latest Information Update: 29 Nov 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Azithromycin (Primary) ; Levofloxacin (Primary) ; Rifaximin (Primary) ; Loperamide
Indications Traveller's diarrhoea
Focus Therapeutic Use
Acronyms TrEAT-TD

24 Nov 2016 Status changed from recruiting to discontinued.
01 Sep 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
19 Jun 2012 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com